MB-Holding

MB Holding GmbH & Co. KG is a private German investment holding company that serves as the primary vehicle for the pharmaceutical interests of entrepreneur Wilhelm Beier. The company is the majority shareholder of Dermapharm Holding SE, a prominent European manufacturer of branded generics and healthcare products. Through its extensive network of subsidiaries, including mibe GmbH Arzneimittel, MB Holding oversees a broad portfolio of dermatological, systemic, and herbal medicinal products. The group gained international prominence for its manufacturing partnership with BioNTech to produce the Comirnaty COVID-19 vaccine at its facilities in Germany. MB Holding continues to focus on the expansion of its healthcare portfolio through both organic growth and targeted acquisitions within the DACH region and internationally.